Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2020-05-21 ROBINS CHAD M CEO and Chairman Sale −50,000 $40.29 $2.0M 1,878,180
2020-05-21 ROBINS CHAD M CEO and Chairman Gift −100,000 1,778,180
2020-05-21 ROBINS CHAD M CEO and Chairman Option exercise · Stock Option (Right to Buy) −50,000 451,560
2020-05-20 ROBINS CHAD M CEO and Chairman Option exercise +50,000 $0.33 $17K 1,928,180
2020-05-20 ROBINS CHAD M CEO and Chairman Sale −50,000 $40.46 $2.0M 1,878,180
2020-05-20 ROBINS CHAD M CEO and Chairman Option exercise · Stock Option (Right to Buy) −50,000 501,560
2020-05-20 ROBINS HARLAN S Chief Scientific Officer Sale −31,372 $40.48 $1.3M 679
2020-05-19 ROBINS CHAD M CEO and Chairman Option exercise +50,000 $0.33 $17K 1,928,180
2020-05-19 ROBINS CHAD M CEO and Chairman Sale −900 $39.31 $35K 1,927,280
2020-05-19 ROBINS CHAD M CEO and Chairman Sale −49,100 $39.95 $2.0M 1,878,180
2020-05-19 ROBINS CHAD M CEO and Chairman Option exercise · Stock Option (Right to Buy) −50,000 551,560
2020-05-19 BENZENO SHARON Chief Business Development Off Option exercise +60,000 $1.98 $119K 60,000
2020-05-19 BENZENO SHARON Chief Business Development Off Option exercise +18,750 $6.32 $119K 78,750
2020-05-19 BENZENO SHARON Chief Business Development Off Option exercise +15,416 $6.27 $97K 94,166
2020-05-19 BENZENO SHARON Chief Business Development Off Option exercise +78,125 $6.55 $512K 172,291
2020-05-19 BENZENO SHARON Chief Business Development Off Option exercise +49,479 $6.55 $324K 221,770
2020-05-19 BENZENO SHARON Chief Business Development Off Option exercise +25,000 $7.27 $182K 246,770
2020-05-19 BENZENO SHARON Chief Business Development Off Sale −246,770 $40.00 $9.9M 0
2020-05-19 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −60,000 0
2020-05-19 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −18,750 1,250

Page 104 of 120 · 2,386 trades